Third Rock Ventures III, L.P. - Insider Trading & Ownership

Entity
Company
Location
29 Newbury Street, 3 Rd Floor, Boston, MA
Summary
The estimated value of insider holdings of Third Rock Ventures III, L.P. is at least $281M dollars as of February 6, 2023. Third Rock Ventures III, L.P. is the 10%+ Owner of Revolution Medicines, Inc. and owns shares of Revolution Medicines, Inc. (RVMD) stock worth about $138M. Third Rock Ventures III, L.P. is the 10%+ Owner of PLIANT THERAPEUTICS, INC. and owns shares of PLIANT THERAPEUTICS, INC. (PLRX) stock worth about $68.4M. Third Rock Ventures III, L.P. is the 10%+ Owner of Nurix Therapeutics, Inc. and owns shares of Nurix Therapeutics, Inc. (NRIX) stock worth about $35.1M. Third Rock Ventures III, L.P. is the 10%+ Owner of Voyager Therapeutics, Inc. and owns shares of Voyager Therapeutics, Inc. (VYGR) stock worth about $22.8M. Third Rock Ventures III, L.P. is the 10%+ Owner of Fulcrum Therapeutics, Inc. and owns shares of Fulcrum Therapeutics, Inc. (FULC) stock worth about $14.3M. Third Rock Ventures III, L.P. is the 10%+ Owner of Jounce Therapeutics, Inc. and owns shares of Jounce Therapeutics, Inc. stock worth about $2.65M.
All Insider Reports
All Insider Reports

Ownership of Third Rock Ventures III, L.P.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
RVMD, RVMDW Revolution Medicines, Inc. 10%+ Owner $138M Jun 8, 2022
PLRX PLIANT THERAPEUTICS, INC. 10%+ Owner $68.4M Nov 29, 2022
NRIX Nurix Therapeutics, Inc. 10%+ Owner $35.1M May 6, 2021
VYGR Voyager Therapeutics, Inc. 10%+ Owner $22.8M Feb 2, 2023
FULC Fulcrum Therapeutics, Inc. 10%+ Owner $14.3M Dec 13, 2022
JNCE Jounce Therapeutics, Inc. 10%+ Owner $2.65M Nov 12, 2021

Insider Transactions Reported by Third Rock Ventures III, L.P.:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.